Asbestos-associated mesothelial cell autoantibodies promote collagen deposition in vitro

Inhalation Toxicology

Volumn 25, Issue 14, 2013, Pages 774-784

  Serve, Kinta M ^a   Black, Brad ^b   Szeinuk, Jaime ^c   Pfau, Jean C ^a  

^a Nucl Eng Idaho State University   (United States)

^b Center for Asbestos Related Disease   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Libby amphibole; Pleural fibrosis

Indexed keywords

ASBESTOS; AUTOANTIBODY; COLLAGEN TYPE 1; GELATINASE B; MATRIX METALLOPROTEINASE; MESOTHELIAL CELL AUTOANTIBODY; NEUTROPHIL COLLAGENASE; OSTEONECTIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; COLLAGEN DEPOSITION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIUM CELL; PLEURAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT; UNITED STATES;

ACTINS; ASBESTOS, AMPHIBOLE; AUTOANTIBODIES; CELL LINE; COLLAGEN; EPITHELIAL CELLS; HUMANS; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; OSTEONECTIN; PLEURA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84889644423     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2013.848249     Document Type: Article

References (69)

1. Antony VB, Hott JW, Kunkel SL, et al. (1995). Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am J Respir Cell Mol Biol 12:581-8.
2. Bandli BR, Gunter ME. (2006). A review of scientific literature examining the mining history, geology, mineralogy, and amphibole asbestos health effects of the Rainy Creek igneous complex, Libby, Montana, USA. Inhal Toxicol 18:949-62.
3. Baroni SS, Santillo M, Bevilacqua F, et al. (2006). Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667-76.
4. Boylan AM, Ruegg C, Kim KJ, et al. (1992). Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestosinduced pleurisy in rabbits. J Clin Invest 89:1257-67.
5. Chizzolini C, Raschi E, Rezzonico R, et al. (2002). Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 46: 1602-13.
6. Chlenski A, Guerrero LJ, Salwen HR, et al. (2011). Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone. PLoS One 6:e23880.
7. Cooper A. (1970). Thermodynamic studies of the assembly in vitro of native collagen fibrils. Biochem J 118:355-65.
8. Dai J, Gilks B, Price K, Churg A. (1998). Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall. Am J Respir Crit Care Med 158:1907-13.
9. Dancer RC, Wood AM, Thickett DR. (2011). Metalloproteinases in idiopathic pulmonary fibrosis. Eur Respir J 38:1461-7.
10. Davila RM, Crouch EC. (1993). Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 142:547-55.
11. Del Papa N, Conforti G, Gambini D, et al. (1994). Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 70:211-16.
12. Fineschi S, Goffin L, Rezzonico R, et al. (2008). Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4. Arthritis Rheum 58:3913-23.
13. Gabrielli A, Svegliati S, Moroncini G, et al. (2007). Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets. Autoimmun Rev 7:121-6.
14. Garcia-Prieto E, Gonzalez-Lopez A, Cabrera S, et al. (2010). Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One 5:e13242.
15. Goldblum SE, Ding X, Funk SE, Sage EH. (1994). SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci U S A 91:3448-52.
16. Griffith DE, Miller EJ, Gray LD, et al. (1994). Interleukin-1-mediated release of interleukin-8 by asbestos-stimulated human pleural mesothelial cells. Am J Respir Cell Mol Biol 10:245-52.
17. Guarino M, Tosoni A, Nebuloni M. (2009). Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum Pathol 40:1365-76.
18. Guo H, Leung JC, Chan LY, et al. (2004). The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis. Rheumatology (Oxford) 43: 286-93.
19. Harris BS, Zhang Y, Card L, et al. (2011). SPARC regulates collagen interaction with cardiac fibroblast cell surfaces. Am J Physiol Heart Circ Physiol 301:H841-7.
20. Harvey W, Amlot PL. (1983). Collagen production by human mesothelial cells in vitro. J Pathol 139:337-47.
21. Hashimoto N, Phan SH, Imaizumi K, et al. (2010). Endothelialmesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 43:161-72.
22. Hedenborg M, Sorsa T, Lauhio A, Klockars M. (1990). Asbestos fibers induce release of collagenase by human polymorphonuclear leukocytes. Immunol Lett 26:25-9.
23. Hinz B, Phan SH, Thannickal VJ, et al. (2007). The myofibroblast: one function, multiple origins. Am J Pathol 170:1807-16.
24. Ihn H, Sato S, Fujimoto M, et al. (2000). Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 119:203-9.
25. Iruela-Arispe ML, Vernon RB, Wu H, et al. (1996). Type I collagendeficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function. Dev Dyn 207:171-83.
26. Kamp DW. (2009). Asbestos-induced lung diseases: an update. Transl Res 153:143-52.
27. Kuwahara M, Kuwahara M, Verma K, et al. (1994). Asbestos exposure stimulates pleural mesothelial cells to secrete the fibroblast chemoattractant, fibronectin. Am J Respir Cell Mol Biol 10:167-76.
28. Lange A. (1980). An epidemiological survey of immunological abnormalities in asbestos workers. II. Serum immunoglobulin levels. Environ Res 22:176-83.
29. Larson TC, Meyer CA, Kapil V, et al. (2010). Workers with Libby amphibole exposure: retrospective identification and progression of radiographic changes. Radiology 255:924-33.
30. Liu JY, Brody AR. (2001). Increased TGF-beta1 in the lungs of asbestosexposed rats and mice: reduced expression in TNF-alpha receptor knockout mice. J Environ Pathol Toxicol Oncol 20:97-108.
31. Liu JY, Morris GF, Lei WH, et al. (1996). Up-regulated expression of transforming growth factor-alpha in the bronchiolar-alveolar duct regions of asbestos-exposed rats. Am J Pathol 149:205-17.
32. Liu Q, Mao H, Nie J, et al. (2008). Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNKSmad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int 28: S88-95.
33. Marchand LS, St-Hilaire S, Putnam EA, et al. (2012). Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT. Toxicol Lett 208: 168-73.
34. Martinek N, Shahab J, Sodek J, Ringuette M. (2007). Is SPARC an evolutionarily conserved collagen chaperone? J Dent Res 86: 296-305.
35. May JV, Frost JP, Schomberg DW. (1988). Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology 123:168-79.
36. Nasreen N, Mohammed KA, Mubarak KK, et al. (2009). Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 297:L115-24.
37. Nigam SK, Suthar AM, Patel MM, et al. (1993). Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J Med Res 98:274-7.
38. Noonan CW, Pfau JC, Larson TC, Spence MR. (2006). Nested casecontrol study of autoimmune disease in an asbestos-exposed population. Environ Health Perspect 114:1243-7.
39. Oh CK, Ariue B, Alban RF, et al. (2002). PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun 294:1155-60.
40. Parsons CJ, Takashima M, Rippe RA. (2007). Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 22(Suppl. 1):S79-84.
41. Peipins LA, Lewin M, Campolucci S, et al. (2003). Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect 111:1753-9.
42. Pershouse MA, Smartt AM, Schwanke C, Putnam EA. (2009). Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs. Genomics 94:101-9.
43. Pfau JC, Li S, Holland S, Sentissi JJ. (2011). Alteration of fibroblast phenotype by asbestos-induced autoantibodies. J Immunotoxicol 8: 159-69.
44. Pfau JC, Sentissi JJ, Weller G, Putnam EA. (2005). Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ Health Perspect 113:25-30.
45. Phan SH. (2002). The myofibroblast in pulmonary fibrosis. Chest 122: 286S-9S.
46. Phan SH. (2008). Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 5:334-7.
47. Piera-Velazquez S, Li Z, Jimenez SA. (2011). Role of endothelialmesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179:1074-80.
48. Renaudineau Y, Revelen R, Levy Y, et al. (1999). Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 6: 156-60.
49. Rentz TJ, Poobalarahi F, Bornstein P, et al. (2007). SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J Biol Chem 282:22062-71.
50. Rohs AM, Lockey JE, Dunning KK, et al. (2008). Low-level fiberinduced radiographic changes caused by Libby vermiculite: a 25-year follow-up study. Am J Respir Crit Care Med 177:630-7.
51. Sage H, Decker J, Funk S, Chow M. (1989a). SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation. J Mol Cell Cardiol 21:13-22.
52. Sage H, Vernon RB, Decker J, et al. (1989b). Distribution of the calciumbinding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem 37:819-29.
53. Scabilloni JF, Wang L, Antonini JM, et al. (2005). Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation. Am J Physiol Lung Cell Mol Physiol 288:L709-17.
54. Siegel RC. (1976). Collagen cross-linking. Synthesis of collagen crosslinks in vitro with highly purified lysyl oxidase. J Biol Chem 251: 5786-92.
55. Strandjord TP, Madtes DK, Weiss DJ, Sage EH. (1999). Collagen accumulation is decreased in SPARC-null mice with bleomycininduced pulmonary fibrosis. Am J Physiol 277:L628-35.
56. Sullivan PA. (2007). Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect 115:579-85.
57. Sung HJ, Johnson CE, Lessner SM, et al. (2005). Matrix metalloproteinase 9 facilitates collagen remodeling and angiogenesis for vascular constructs. Tissue Eng 11:267-76.
58. Tamura M, Liang D, Tokuyama T, et al. (1993). Study on the relationship between appearance of autoantibodies and chest X-ray findings of asbestos plant employees. Sangyo Igaku 35:406-12.
59. Tamura M, Tokuyama T, Kasuga H, et al. (1996). Study on correlation between chest X-P course findings and change in antinuclear antibody in asbestos plant employees. Sangyo Eiseigaku Zasshi 38:138-41.
60. Tan RJ, Fattman CL, Niehouse LM, et al. (2006). Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol 35:289-97.
61. Wang JC, Lai S, Guo X, et al. (2010). Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther 12:R60. doi:10.1186/ar2973.
62. Whitehouse AC. (2004). Asbestos-related pleural disease due to tremolite associated with progressive loss of lung function: serial observations in 123 miners, family members, and residents of Libby, Montana. Am J Ind Med 46:219-25.
63. Whitehouse AC, Black CB, Heppe MS, et al. (2008). Environmental exposure to Libby Asbestos and mesotheliomas. Am J Ind Med 51: 877-80.
64. Willis BC, Liebler JM, Luby-Phelps K, et al. (2005). Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321-32.
65. Wynn TA. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524-9.
66. Wynn TA. (2008). Cellular and molecular mechanisms of fibrosis. J Pathol 214:199-210.
67. Zavadil J, Bottinger EP. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764-74.
68. Zhang HY, Gharaee-Kermani M, Zhang K, et al. (1996). Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 148:527-37.
69. Zhang K, Rekhter MD, Gordon D, Phan SH. (1994). Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 145:114-25.